Forced degradation of therapeutic proteins

Andrea Hawe, Michael Wiggenhorn, Marco van de Weert, Joerg H. O. Garbe, Hanns-Christian Mahler, Wim Jiskoot

    154 Citations (Scopus)

    Abstract

    The scope of this paper is to review approaches used for forced degradation (synonym, stress testing) of therapeutic proteins. Forced degradation studies play a central role in the development of therapeutic proteins, for example, for candidate selection, molecule characterization, formulation development, assay development, and comparability studies. Typical stress methods are addressed within this review, such as exposure to elevated temperatures, freeze-thawing, mechanical stress, oxidation, light, as well as various materials and devices used in the clinics during final administration. Stability testing is briefly described as far as relevant to the discussion of forced degradation studies. Whereas stability-testing requirements are defined in regulatory guidelines, standard procedures for forced degradation of therapeutic proteins are largely unavailable, except for photostability. Possible selection criteria to identify appropriate stress conditions and recommendations for setting up forced degradation studies for the different phases of development of therapeutic proteins are presented.

    Original languageEnglish
    JournalJournal of Pharmaceutical Sciences
    Volume101
    Issue number3
    Pages (from-to)895-913
    ISSN0022-3549
    DOIs
    Publication statusPublished - Mar 2012

    Keywords

    • Former Faculty of Pharmaceutical Sciences

    Fingerprint

    Dive into the research topics of 'Forced degradation of therapeutic proteins'. Together they form a unique fingerprint.

    Cite this